| scholarly article | Q13442814 |
| P356 | DOI | 10.1164/RCCM.200705-742OC |
| P8608 | Fatcat ID | release_wroryhmc5zhntpmrejpsh335ey |
| P698 | PubMed publication ID | 17975200 |
| P50 | author | Gernot Zissel | Q41525754 |
| Joachim Müller-Quernheim | Q47008767 | ||
| Antje Prasse | Q47008769 | ||
| P2093 | author name string | Antje Prasse | |
| Martin Germann | |||
| Armin Buchwald | |||
| Christine Katic | |||
| P2860 | cites work | Serum soluble interleukin-2 receptor measurement in patients with sarcoidosis: a clinical evaluation | Q47769722 |
| Sarcoidosis: the value of exercise testing | Q49163411 | ||
| HLA-DQB1*0201: a marker for good prognosis in British and Dutch patients with sarcoidosis. | Q51702366 | ||
| Genetic linkage of systemic lupus erythematosus to 13q32 in African American families with affected male members. | Q53655610 | ||
| Sarcoidosis | Q54152750 | ||
| Genotype-corrected reference values for serum angiotensin-converting enzyme. | Q54569326 | ||
| Sarcoidosis | Q56656053 | ||
| Study of C-C Chemokine Receptor 2 Alleles in Sarcoidosis, with Emphasis on Family-based Analysis | Q57569188 | ||
| Sex-specific manifestations of Löfgren's syndrome | Q24684067 | ||
| Phenotypic and genetic heterogeneity in a genome-wide linkage study of asthma families | Q24802953 | ||
| Primary Pulmonary Sarcoidosis.1 | Q29038246 | ||
| Sarcoidosis is associated with a truncating splice site mutation in BTNL2. | Q34398412 | ||
| HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis | Q34446770 | ||
| Presenting characteristics as predictors of duration of treatment in sarcoidosis | Q34566301 | ||
| Is there a role for microorganisms in the pathogenesis of sarcoidosis? | Q35067110 | ||
| A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18. | Q40328974 | ||
| Selective induction of mononuclear phagocytes to produce neopterin by interferons | Q43501360 | ||
| Clinical characteristics of patients in a case control study of sarcoidosis | Q44248269 | ||
| Evaluation of soluble CD 14 and neopterin as serum parameters of the inflammatory activity of pulmonary sarcoidosis | Q44341011 | ||
| Bronchoalveolar and serological parameters reflecting the severity of sarcoidosis | Q44380093 | ||
| The roentgenographic staging of sarcoidosis. Historic and contemporary perspectives | Q47584584 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 330-336 | |
| P577 | publication date | 2007-11-01 | |
| P1433 | published in | American Journal of Respiratory and Critical Care Medicine | Q4744267 |
| P1476 | title | Phenotyping sarcoidosis from a pulmonary perspective | |
| P478 | volume | 177 |
| Q90753306 | Bronchoalveolar lavage characteristics correlate with HLA tag SNPs in patients with Löfgren's syndrome and other sarcoidosis |
| Q51446576 | CTAS: a CT score to quantify disease activity in pulmonary sarcoidosis. |
| Q36924965 | Calcium and Vitamin D in Sarcoidosis: How to Assess and Manage |
| Q36738614 | Circulating cytokines in sarcoidosis: phenotype-specific alterations for fibrotic and non-fibrotic pulmonary disease |
| Q50618523 | Diagnostic value of strain echocardiography, galectin-3, and tenascin-C levels for the identification of patients with pulmonary and cardiac sarcoidosis. |
| Q36652857 | Elevated 1, 25-dihydroxyvitamin D levels are associated with protracted treatment in sarcoidosis |
| Q58564538 | Epidemiology of sarcoidosis: current findings and future directions |
| Q51572961 | Factors signifying gender differences in clinical presentation of sarcoidosis among Estonian population. |
| Q37470312 | Familial vs. sporadic sarcoidosis: BTNL2 polymorphisms, clinical presentations, and outcomes in a French cohort |
| Q64270443 | First patient-centred set of outcomes for pulmonary sarcoidosis: a multicentre initiative |
| Q38290398 | Functional Toll-Like Receptor 9 Expression and CXCR3 Ligand Release in Pulmonary Sarcoidosis |
| Q45400928 | Granulomatous lung and systemic diseases |
| Q84763968 | Human chitotriosidase: a sensitive biomarker of sarcoidosis |
| Q39876461 | Inhaled vasoactive intestinal peptide exerts immunoregulatory effects in sarcoidosis. |
| Q34248475 | Interferon-inducible chemokines reflect severity and progression in sarcoidosis |
| Q35901288 | Interleukin-2 Receptor and Angiotensin-Converting Enzyme as Markers for Ocular Sarcoidosis |
| Q51141920 | Prognostic markers of sarcoidosis: an analysis of patients from everyday pneumological practice. |
| Q54974263 | Role of serum immunoglobulins for predicting sarcoidosis outcome: A cohort study. |
| Q86442315 | Sarcoidosis |
| Q95565170 | Sarcoidosis |
| Q47665654 | Sarcoidosis: a review for the internist |
| Q38906817 | Serum soluble interleukin-2 receptor level is more sensitive than angiotensin-converting enzyme or lysozyme for diagnosis of sarcoidosis and may be a marker of multiple organ involvement |
| Q38255985 | The Clinical Features of Sarcoidosis: A Comprehensive Review |
| Q37241249 | The Diagnosis, Differential Diagnosis, and Treatment of Sarcoidosis |
| Q41862598 | The clinical and immunologic features of pulmonary fibrosis in sarcoidosis |
| Q85166712 | The impact of gas exchange measurement during exercise in pulmonary sarcoidosis |
| Q37377865 | Up-to-date in pulmonary and extrapulmonary sarcoidosis |
| Q85773001 | Use of discriminant analysis in assessing pulmonary function worsening in patients with sarcoidosis by a panel of inflammatory biomarkers |
| Q58697264 | YKL-40, Soluble IL-2 Receptor, Angiotensin Converting Enzyme and C-Reactive Protein: Comparison of Markers of Sarcoidosis Activity |
| Q86690923 | [Diagnosis and treatment of sarcoidosis. Current standards] |
| Q86704225 | [Genetic risk profile of sarcoidosis] |
| Q89371391 | [Sarcoidosis] |
| Q34606534 | [Sarcoidosis]. |
Search more.